CMS Open Payments · Program Year 2024
Sequence LifeScience, Inc
Sequence LifeScience, Inc reported $194,500.00 in payments to 64 physicians and teaching hospitals across 64 transactions.
- $194.5K
- Total payments
- 64
- Transactions
- 64
- Recipients
- #1008
- of 1,925 companies
Sequence LifeScience, Inc reported $194,500.00 in payments to 64 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1008 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $3.0K per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
The verdict
Sequence LifeScience, Inc pairs below-median payment volume with a concentrated payment pattern focused on a handful of top recipients.
- #1008
- of 1,925 companies
- 0.0%
- of all US industry payments
- 0.8%
- paid to its single top recipient
- 1
- payment categories
How Sequence LifeScience, Inc ranks nationally
Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.
Sequence LifeScience, Inc's total vs. every reporting company
CMS Open Payments, Program Year 2024
$194,500 48th percentile higher than 48% of 1,925 reporting companies
Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Open Payments · 2024
What the Data Shows for Sequence LifeScience, Inc
Averaging $3.0K per transaction and $3.0K per recipient, Sequence LifeScience, Inc's Program Year 2024 total comes to $194,500.00 across 64 transactions and 64 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #1008 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
"Consulting Fee" leads the 1-category general-payment breakdown below at $194.5K (100.0% of the company's reported total, 64 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Sequence LifeScience, Inc made 1 types of general payments. "Consulting Fee" is the largest category at $194.5K, 100.0% of the company's reported total.
How Sequence LifeScience, Inc divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $194.5K | 64 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $194,500.00 (100.0%) of $194,500.00 in this company's General Payments records across 2 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Sequence LifeScience, Inc
The five named recipients with the highest reported General Payments from this company
- 1
Michael Bauer
$164,500.00 across 52 reported transactions
- 2
Walter Strash
$30,000.00 across 12 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Payment Size Analysis
Average transaction size: $3.0K. Average per recipient: $3.0K.
Total Amount
$194,500.00
Avg per Transaction
$3.0K
Avg per Recipient
$3.0K
Payment Transparency Context
What is the Sunshine Act?
The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.
Industry Total (2024)
$13.9B
across 1,925 companies
Sequence LifeScience, Inc Share
0.0%
#1008 by total payments
Companies with Similar Payment Volumes
Pharmaceutical companies with payment totals similar to Sequence LifeScience, Inc
Frequently Asked Questions
How much did Sequence LifeScience, Inc pay to physicians and hospitals in 2024? ▾
How many physicians received payments from Sequence LifeScience, Inc? ▾
What types of payments did Sequence LifeScience, Inc make? ▾
How does Sequence LifeScience, Inc rank among pharmaceutical companies? ▾
What is the average payment size from Sequence LifeScience, Inc? ▾
Where does the payment data for Sequence LifeScience, Inc come from? ▾
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.